Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Acquired hemophilia A (AHA) is an autoimmune disease caused by an autoantibody to
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study
A Tiede, R Klamroth, RE Scharf… - Blood, The Journal …, 2015 - ashpublications.org
Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII).
Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of …
Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of …
Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study
SJ Schep, WEM Van Dijk, EAM Beckers… - American Journal of …, 2021 - Wiley Online Library
Acquired hemophilia A (AHA) is a severe auto‐immune bleeding disorder. Treatment of AHA
is burdensome and optimal management is still unresolved. Therefore a retrospective …
is burdensome and optimal management is still unresolved. Therefore a retrospective …
[HTML][HTML] Treatment of acquired hemophilia A
PW Collins - Journal of Thrombosis and Haemostasis, 2007 - Elsevier
Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe
bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes …
bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes …
Acquired hemophilia A: updated review of evidence and treatment guidance
R Kruse‐Jarres, CL Kempton, F Baudo… - American journal of …, 2017 - Wiley Online Library
Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors)
against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and …
against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and …
Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.
J Delgado, V Jimenez-Yuste… - British journal of …, 2003 - search.ebscohost.com
Focuses on clinical features, laboratory diagnosis, prognostic factors and therapeutic
management of patients with acquired hemophilia. Association of acquired hemophilia with …
management of patients with acquired hemophilia. Association of acquired hemophilia with …
The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
RL Bitting, S Bent, Y Li, J Kohlwes - Blood coagulation & …, 2009 - journals.lww.com
The inhibition of factor VIII by autoantibody development, or acquired hemophilia, occurs in
approximately one person per million each year and can cause life-threatening bleeding …
approximately one person per million each year and can cause life-threatening bleeding …
[HTML][HTML] International recommendations on the diagnosis and treatment of acquired hemophilia A
Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …
Advances in the understanding of acquired haemophilia A: implications for clinical practice
PW Collins, CL Percy - British journal of haematology, 2010 - Wiley Online Library
Acquired haemophilia A is an auto‐immune disease caused by an inhibitory antibody to
factor VIII. Patients with an acquired factor VIII inhibitor are at risk of life‐and limb …
factor VIII. Patients with an acquired factor VIII inhibitor are at risk of life‐and limb …
Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry
JY Borg, B Guillet, V Le Cam‐Duchez… - …, 2013 - Wiley Online Library
Although extremely rare, acquired haemophilia A (AHA) can cause severe bleeding, which
may be fatal. The underlying causes of autoantibody development are not fully understood …
may be fatal. The underlying causes of autoantibody development are not fully understood …
相关搜索
- acquired hemophilia balancing act
- acquired hemophilia prognostic factors
- acquired hemophilia diagnosis and treatment
- acquired hemophilia meta analysis
- acquired hemophilia international recommendations
- acquired haemophilia advances in the understanding
- acquired haemophilia clinical practice
- acquired hemophilia treatment guidance
- acquired hemophilia prognosis and treatment
- acquired haemophilia prognostic factors
- acquired haemophilia meta analysis